Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
adjunct, AI, anticancer, Ascend, aspect, assimilated, authentication, begun, bev, biopsy, bipartisan, Bridge, Chamber, Clawback, Commerce, Concrete, Convatec, CSMT, cyber, cybersecurity, debated, delisted, Delisting, depositor, discriminated, divorcing, East, EDIT, Erroneously, exacerbate, Excellence, exosomal, explanatory, feedback, Fellow, Florida, front, Genentech, geopolitical, grace, GSK, hacking, hardware, honorary, hosted, implicated, infiltrate, intrusion, ipilimumab, Irish, Kanna, Kinaset, Leaseback, Lifecycle, lock, locked, Lothian, malware, MDAI, Meta, Middle, multifactor, Mutagenicity, NCSC, Neurone, NHS, OTC, patch, pathologist, PBM, perpetrated, Pillar, placement, portal, postpone, posture, prompt, PsiClone, quotation, ransomware, rationale, RDEC, recurring, regain, repayment, reticent, RTOR, runway, Senate, session, simplified, simplify, SMD, sophistication, standalone, straightforward, streamline, streamlined, sweeping, theft, threat, topline, transmit, triage, uncorrected, underway, unemployment, unintentional, withdrew, Wugen, Xencor
Removed:
advent, afflicted, Agriculture, alive, analyzed, biologically, British, Century, CJEU, CLIO, combining, comparison, Conceptual, curve, derecognition, deriving, disappearance, distinctive, downregulate, doxorubicin, draft, emergency, enactment, equally, exploit, FDASIA, fifteen, footnote, formed, Fulfilling, Gastroenterology, grown, instance, investigated, journal, lesion, liposomal, markedly, Michael, mixture, moderate, modernize, paclitaxel, PARP, peak, pegylated, Powell, preissuance, prodrug, reauthorized, reclassified, rulemaking, scoring, sourced, spur, survived, synergy, thrombocytopenia, topotecan, transient, Trump, undergone, underwent, unrestricted, unsuitable, worsen
Filing tables
Filing exhibits
NCNA similar filings
Filing view
External links
Exhibit 13.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Donald Munoz, Chief Financial Officer of NuCana plc (the “Company”), hereby certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:
1.
The Annual Report on Form 20-F of the Company for the period ended December 31, 2023 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: March 20, 2024 |
| /s/ Donald Munoz |
|
| Donald Munoz |
|
| Chief Financial Officer |
|
| (Principal Financial Officer) |